Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest
Sclerotherapy of reticular and telangiectatic veins of the face, hands, and chest
复制标题
DOI：
10.1046/j.1524-4725.2002.01154.x
复制
发表时间：
2002-01-01
影响因子：
2.4
通讯作者：
Goldman, MP
中科院分区：
文献类型：
--
作者：
Bowes, LE;Goldman, MP
背景资料。面部和手部的突出曲折的静脉可能是衰老过程中的结果，并构成许多患者的痛苦来源。目的：探讨硬化剂治疗面部和面部毛细血管扩张性静脉和手部静脉曲张的安全性和有效性。方法：对14例20个面部毛细血管扩张症和静脉曲张患者的20个面部部位进行硬化剂治疗。患者没有胶原蛋白血管疾病，没有慢性疾病，并被彻底告知手术的严格美容性质。在20个部位中有16个部位使用了高渗硬化剂，其余4个部位用洗涤剂硬化剂(聚多糖醇0.5-0.75%)处理。术后随访9个月至15年。同样，对7名患者的14只手的静脉曲张进行硬化治疗，使用不同浓度(1-3%)的去污剂硬化剂[十四烷基硫酸钠(STS)]。术后随访1~6.5年。对3例胸部曲张静脉和毛细血管扩张患者进行了0.25~0.50%的STS或0.75%的聚多烯醇治疗，随访2~9年。结果：面部静脉曲张和毛细血管扩张平均改善70%，20个部位中有11个改善90~100%。手部静脉曲张平均改善97.8%，所有部位静脉曲张的消失率为90-100%。最后，经硬化治疗后，胸部曲张的静脉和毛细血管扩张改善了50%-100%。仅在两名患者中观察到轻微至中度的毛细血管扩张垫(一名患者位于外侧内斜区，一名患者位于胸廓网状静脉治疗部位附近)。面静脉和手部静脉长期未见溃疡或色素沉着。1例患者左侧乳房发生动脉溃疡。结论：面部、手部和胸部的静脉曲张和毛细血管扩张的硬化治疗是安全和有效的。必须注意胸部区域的硬化治疗，特别是乳房。
BACKGROUND. Prominent tortuous veins of the face and hands may result from the process of aging and constitute a source of distress for many patients. Marked telangiectases of the chest and face are similarly distressing to some patients.OBJECTIVE. To determine the safety and efficacy of sclerotherapy for telangiectatic veins of the face and chest and varicose veins of the hands.METHODS. Twenty facial telangiectases and tortuous veins in 14 patients and 20 total facial sites were treated with sclerotherapy. Patients did not suffer from collagen vascular diseases, had no chronic illnesses, and were thoroughly informed of the strictly cosmetic nature of the procedure. A hyperosmolar sclerosant was used in 16 of 20 sites and the remaining 4 sites were treated with a detergent sclerosant (polidocanol 0.5-0.75%). The follow-up period ranged from 9 months to 15 years. Similarly the varicose veins of 14 hands in seven patients were treated with sclerotherapy using a detergent sclerosant [sodium tetradecyl sulfate (STS)] at various concentrations (1-3%). The follow-up period ranged from 1 to 6.5 years. Tortuous veins and telangiectases on the chest of three patients were treated with either STS 0.25-0.50% or polidocanol 0.75% with a follow-up of 2-9 years.RESULTS. Tortuous facial veins and telangiectases had a mean improvement of 70%, with 11 of 20 sites showing a 90-100% improvement. Hand varicosities had a mean improvement of 97.8%, and all sites showed a 90-100% resolution of varicosities. Finally, the tortuous veins and telangiectases of the chest improved by 50-100% with sclerotherapy. Only minimal to moderate telangiectatic matting was observed in two patients (one in the lateral canthal area and one near the treatment site of chest reticular veins). No ulceration or hyperpigmentation occurred long term in facial or hand veins. One patient developed an arterial ulceration on the left lateral breast.CONCLUSION. Sclerotherapy of varicose and telangiectatic veins of the face, hands, and chest can be safe and effective. Care must be given to sclerotherapy in the chest area, particularly the breast.